Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Transitional Cell × niraparib × Clear all

Sponsor

Conditions

Ovarian Neoplasms 15 Breast Neoplasms 6 Neoplasms 5 Fallopian Tube Neoplasms 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Triple Negative Breast Neoplasms 2 Prostatic Neoplasms, Castration-Resistant 2 Neoplasm Metastasis 2 Esophageal Neoplasms 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Stomach Neoplasms 1 Prostate Adenocarcinoma 1 Pancreatic Adenocarcinoma 1 Osteosarcoma 1 Oligodendroglioma 1 Neuroblastoma 1 Metastatic Castration-sensitive Prostate Cancer 1 Mesothelioma 1 Melanoma 1 Lung Neoplasms 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Cholangiocarcinoma 1

Interventions

pembrolizumab 21 atezolizumab 12 Gemcitabine 12 Nivolumab 10 Cisplatin 10 Docetaxel 8 Carboplatin 8 Mitomycin 5 avelumab 4 Ipilimumab 4 pemigatinib 3 epacadostat 3 Paclitaxel 3 Bevacizumab 3 vofatamab 2 lenvatinib 2 enfortumab vedotin 2 cabozantinib 2 cabazitaxel 2 bempegaldesleukin 2 Standard of Care 2 Rogaratinib 2 Ramucirumab 2 Platinum 2 Pemetrexed 2 Everolimus 2 Biopsy 2 B701 protein, Human herpesvirus 6 2 Albumin-Bound Paclitaxel 2 1,2-diaminocyclohexaneplatinum II citrate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡